Asia Pacific Archives - Page 3 of 9 - Journal for Clinical Studies

Current Edition

Asia Pacific

Brand new type of cancer drug has potential to fill unmet needs in oncology market, says GlobalData

Following a study published in The Lancet Oncology regarding a brand new type of cancer drug that has shown promise in multiple cancer types in early Phase I/II tria...

Continue Reading →

Asia Pacific

Despite recent setbacks, the ophthalmology market still offers vast potential, says GlobalData

Despite the ophthalmology market experiencing several research and development (R&D) setbacks during 2018, the launch of three new drugs highlights that the mark...

Continue Reading →

Asia Pacific

EXUMA Biotech acquires strategic CAR-T assets

EXUMA Biotech integrates BioAtla's conditionally active biologic (CAB) protein therapeutic technology with F1 Oncology's proprietary CAR-T technologies to develop and...

15 November 2018 Asia Pacific | news

Continue Reading →

Asia Pacific

New drug kills antibiotic-resistant bacteria in clinical trial

Antibiotic resistance is a major obstacle that modern medicine is currently grappling with. It has created crisis situations around the world, and researchers are try...

1 November 2018 Asia Pacific | news | North America

Continue Reading →

Asia Pacific

Yisheng receives approval for rabies vaccine clinical study

The PIKA rabies vaccine has completed Phase I and Phase II clinical studies in Singapore. Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on...

18 October 2018 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Fiasp is effective at controlling blood sugar levels in children and adolescents living with type 1 diabetes, when compared to conventional insulin aspart

Hyderabad, India, 12 October 2018 - For children and adolescents (1 to <18 years old) living with type 1 diabetes, Fiasp® (an ultra-fast acting formulation of ins...

18 October 2018 Asia Pacific | news | Regional News

Continue Reading →

Asia Pacific

Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis

Servier, an independent international pharmaceutical company, and the company Galapagos NV announce the start of a global Phase 2 trial with S201086/GLPG1972 in knee...

Continue Reading →

Asia Pacific

Blockchain to Combat Type 2 Diabetes Epidemic in India

Genomics pioneer Shivom hopes to transform diagnosis and treatment of a disease that’s pervasive in the country. London, UK - 25 September 2018: A pioneering diabetes...

3 October 2018 Asia Pacific | Europe | news | Regional News

Continue Reading →

Asia Pacific

Addressing social and cultural drivers of type 2 diabetes is key to its treatment and prevention

Berlin, Germany, 2 October 2018 - New research shows healthcare services and public health strategies aimed at reducing the burden of type 2 diabetes may prove ineffe...

3 October 2018 Asia Pacific | Europe | Latin America | news | Regional News

Continue Reading →

Asia Pacific

GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102 in patients with advanced or metastatic colorectal cancer

C201 phase 2 will study immuno-enhancer antibody GM102, targeting AMHRII as a single agent and in combination with Trifluridine/Tipiracil (Lonsurf®) Paris and Toulou...

Continue Reading →